GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Short-Term Capital Lease Obligation

Whanin Pharm Co (XKRX:016580) Short-Term Capital Lease Obligation : ₩370 Mil (As of Jun. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Short-Term Capital Lease Obligation?

Whanin Pharm Co's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₩370 Mil.

Whanin Pharm Co's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (₩325 Mil) to Mar. 2024 (₩335 Mil) and increased from Mar. 2024 (₩335 Mil) to Jun. 2024 (₩370 Mil).

Whanin Pharm Co's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩416 Mil) to Dec. 2022 (₩186 Mil) but then increased from Dec. 2022 (₩186 Mil) to Dec. 2023 (₩325 Mil).


Whanin Pharm Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Whanin Pharm Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Short-Term Capital Lease Obligation Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 426.51 546.59 415.86 186.32 324.97

Whanin Pharm Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 333.80 314.89 324.97 334.72 369.87

Whanin Pharm Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Whanin Pharm Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines